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The herpesvirus lifestyle results in a long-term interaction between host and invading pathogen,
resulting in exquisite adaptation of virus to host. We have sequenced the genomes of nine strains of
murine cytomegalovirus (a betaherpesvirus), isolated from free-living mice trapped at locations
separated geographically and temporally. Despite this separation these genomes were found to have
low levels of nucleotide variation. Of the more than 160 open reading frames, almost 90% had a dN/dS
ratio of amino acid substitutions of less than 0.6, indicating the level of purifying selection on the
coding potential of MCMV. Examination of selection acting on individual genes at the codon level
however indicates some level of positive selection, with 0.03% of codons showing strong evidence for
positive selection. Conversely, 1.3% of codons show strong evidence of purifying selection. Alignments
of both genome sequences and coding regions suggested that high levels of recombination have shaped
the MCMV genome.
Crown Copyright & 2012 Published by Elsevier Inc. All rights reserved.Introduction
The host immune system strives to control the replication of
invading viral pathogens, mediating tissue damage and disease,
and thus at a population level controls the potential of the virus to
transmit to a new host. Viral mutants mostly arise due to
polymerase inﬁdelity or recombination, but mutations which
are selected within a viral population are those which confer
some ﬁtness advantage to the virus such as escape of immune
surveillance, differential replication or transmission. Point mutations
accumulate over generational time and their retention within the
virus population is mediated by selection of non-deleterious mutants.
For some viral species, the rate of recombination is reported to exceed
the point mutation rate (Urbanowicz et al., 2005; Wain-Hobson et al.,
2003) and may result in a seismic shift in sequence and thus a more
rapid change in viral phenotype (Mild et al., 2007; Monci et al., 2002;
Nora et al., 2007).
Much of the research on viral variation or recombination at the
genome scale utilises viruses with small genomes and fast
replication rates (Froissart et al., 2005; Moutouh et al., 1996;
Nora et al., 2007); however, with the advent of next generation
sequencing technology, analyses of large DNA viruses are becom-
ing possible (Bradley et al., 2009; Cunningham et al., 2010).012 Published by Elsevier Inc. All
stern Australia,
stralia.
edwood).Cytomegaloviruses are large ds-DNA viruses (beta-herpesviruses)
which are generally considered to have co-speciated with their
mammalian hosts and this, in combination with their disease
resolution (persistent asymptomatic infection and the capacity to
enter latency) provides the basis for the exquisite adaptation of
viral pathogen to its host. Evidence for recombination can be seen
in alpha- and gamma-herpesviruses by analysis of sequences from
circulating or clinically derived virus strains (Achour et al., 2008;
Midgley et al., 2000; Norberg et al., 2007; Walling et al., 1995), and
can be demonstrated experimentally by co-infection in vitro
(Dohner et al., 1988; Fujita et al., 1998; Meurens et al., 2004;
Schynts et al., 2001), and in vivo (Javier et al., 1986; Muylkens et al.,
2009). Indeed, some experimental systems yield recombination
frequencies up to 45% (Brown et al., 1992; Muylkens et al., 2009;
Schynts et al., 2003). However, recombination in betaherpesviruses
is poorly described. There are early reports of experimentally
identiﬁed recombination between strains of human cytomegalo-
virus (Chou, 1989; Haberland et al., 1999), with other evidence
limited to identiﬁcation of conﬂicting phylogenetic signals within
variable viral genes (Faure-Della Corte et al., 2010; Garrigue et al.,
2007; Steininger, 2007; Steininger et al., 2005; Yan et al., 2008).
Murine CMV (MCMV) is the most widely used animal model for
human CMV infection. Both HCMV and MCMV establish latent
infection that reactivates upon immunosuppression, and the course
of infection and the type of pathology seen are essentially identical.
The persistent nature of MCMV infection provides a basis for viral
escape from host immune control, and the tendency for hosts to be
infected with multiple distinct strains of CMV (Booth et al., 1993;rights reserved.
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recombination. The genome of the laboratory strain of MCMV was
sequenced in 1996 (Rawlinson et al., 1996), and we subsequently
published genome sequences of four further viral strains in 2008
(Smith et al., 2008). We describe here the genomes of a further six
strains of MCMV—and therefore we have genome sequences of 11
distinct strains of MCMV separated in their isolation both tempo-
rally (by up to 50 years) and distally (maximum distance approxi-
mately 17,500 km). We show that the MCMV genome has
undergone extensive recombination, yet is highly conserved with
a large proportion of the coding potential of the virus evolving
under purifying selection.Results and discussion
We have a collection of MCMV strains, isolated from free-
living mice (Mus domesticus) captured at distal locations through-
out Australia and from several islands. It has previously been
demonstrated that MCMV strains have distinct growth capacities
in different inbred mouse strains (Booth et al., 1993; Corbett et al.,
2010; Smith et al., 2008; Voigt et al., 2003) suggesting differential
evasion of host resistance and immune mechanisms. In addition
to the sequences previously published (Smith et al., 2008) we
have now sequenced the entire genomes of a further six viral
strains. Of the nine Australian viral strains sequenced, two are
from mainland Western Australia (G4, N1) and one (NO7) from
Beacon Island (off the Western Australian coast). Five of the
strains (C4A, B, C, D and WP15B) are from south/eastern Australia,
separated from WA by 3000 km. One strain (AA18d) was isolated
from a mouse trapped on Macquarie Island (approximately
2300 km from mainland Australia). It is generally assumed that
mice arrived in Australia with European settlement, with limited
secondary colonisation (Gabriel et al., 2011). Free-living mice on
Macquarie Island are believed to be distinct from those on
mainland Australia, having been introduced by sealers in the late
19th century (Cumpston, 1968; Kidder, 1876) or from shipwrecks
earlier in the century. Given the distances between the sites from
which these viruses were isolated, and that interbreeding and
migration happens rarely, if at all, even between closely located
populations of mice (Murphy et al., 2005) we feel justiﬁed in
treating them as coming from distinct mouse populations. Simi-
larly the virus strains are isolated temporally, with the Smith
strain of virus ﬁrst isolated in the early 1950s, compared to G4/N1
(mid-1980s), C4A/B/C/D/WP15B (mid-1990s), and NO7 (2005). All
of the viruses were sequenced using 454 technology except Smith
which was sequenced using Sanger sequencing. K181, G4, C4A
and WP15B were sequenced using the GS20 platform, and the
other ‘wild’ viruses were sequenced using the GSFlx platform.
Whilst the error rates of the different platforms are known, it is
interesting to assess the results derived from the different plat-
forms. For example, comparing the GS20 sequenced viruses to
Smith, we identiﬁed several errors which were only found in the
Sanger sequenced virus (Smith et al., 2008), which perhaps reﬂects
the depth of sequence coverage used. The genome sequences of the
11 completely sequenced MCMV strains were aligned, and the level
of nucleotide diversity assessed. As previously identiﬁed (Smith
et al., 2008) the level of genetic variability is highest at the genomic
termini, however overall genome-wide nucleotide diversity (P) is
0.01470. This is approximately half the level of variability seen in
alignments of the UL region from published HCMV sequences
(P¼0.02818), and both MCMV and HCMV have much higher levels
of nucleotide diversity than the alpha-herpesviruses HSV-1 (P¼
0.0022–0.0056) and VZV (P¼0.00063). The inherent error rates of
both HCMV and MCMV polymerases have been assessed during
serial in vitro passage (Cheng et al., 2010; Dargan et al., 2010). Inboth cases, the error rates are consistent with those determined by
phylogenetic analysis. Recent work by Renzette et al. (2011)
utilising high throughput deep sequencing of HCMV strains from
congenitally infected infants, suggested a much higher degree of
nucleotide variability (P¼0.18–0.25), almost of the order of
variability seen in Dengue and HIV sequences. However, the
contrast between this data, and both our calculations from pub-
lished HCMV sequences (above) and mutations seen during in vitro
passage, suggests that this level of variability may be related to the
increased viral titres seen in the individuals sampled (4107 pfu/ml
in urine samples from congenitally infected infants compared to, for
example, approximately 5104 pfu/ml in brocheolar lavage of
transplant patients (Gorzer et al., 2010)). Additionally, it has been
reported that, as a minimal estimate, 39% of congenitally infected
individuals may be infected with multiple strains of HCMV (Ross
et al., 2011), which has the capacity to confound reports based on
direct sequencing of clinical samples. The difference between the
levels of variation reported in the congenital system as opposed to
the level determined by sequence analysis of clinical strains of
HCMV would also indicate that HCMVmutation generally results in
reduced viral ﬁtness and transmissibility. There is no evidence that
MCMV undergoes passage related mutation as seen for HCMV—
indeed MCMV strains appear to be highly stable during passage, as
K181 strains which have been separated for at least 30 years and
subjected to in vitro passage for uncounted generations differ by
only 13 nucleotides, nine of which are in a single gene (Timoshenko
et al., 2009). It remains possible that the MCMV genome does
undergo some early adaptation to tissue culture. However, without
sequencing directly from infected salivary glands this would be
difﬁcult to detect. It is worth noting however that if cell culture
adaptations do occur, they appear to have little in vivo effect as all
of the sequenced strains are capable of replicating within immu-
nocompetent mice (Smith et al., 2008, and unpublished data). The
lack of the type of intra-preparation variability seen by Renzette
et al. can also be seen by the near identity of the sequence of sister
plaque-puriﬁed viruses (Cheng et al., 2010), and of BAC-cloned to
parental virus (unpublished data and Jordan, et al., 2011).
It is interesting to note that nucleotide diversity within the
four viruses isolated from the same individual (C4A, B, C, D,
P¼0.01395) was only slightly lower than for the remaining seven
genomes (P¼0.01525), indicating these are independent viral
strains rather than intra-host variants produced during infection.
MCMV has a chimeric genome
Given the low error rate of herpesvirus DNA polymerases, and
thus the low level of sequence variation in most herpesviral
genes, it is considered that one of the major mechanisms by
which herpesvirus genomes evolve is by recombination. This is
also suggested by the fact that several HCMV and MCMV genes
exist within viral populations as distinct genotypes (Bar et al.,
2001; Gorzer et al., 2008; Heo et al., 2008; Smith et al., 2006),
which may be exchanged between viral strains. However, little is
known about the contribution of intermolecular recombination
(i.e. recombination between co-infecting strains) to the architec-
ture of betaherpesvirus genomes. Given the lack of sterilising
immunity in MCMV infection, and that infection of the host with
multiple strains of virus seems to be common (Booth et al., 1993;
Gorman et al., 2006; Grosjean et al., 2009; Numazaki et al., 1998),
in addition to the life-long, persistent nature of CMV infections,
the potential for recombination is obvious. The aligned viral
genomes sequences were examined for evidence of recombina-
tion using SplitsTree. A reticulate phylogenetic network was
evident, due to the presence of conﬂicting phylogenetic signals
within the sequences (Fig. 1). The PHI test for recombination was
performed, which conﬁrmed that these conﬂicting signals are due
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tial impact of recombination on coding regions, we examined
individual gene sequences. Codon-aligned gene sequences from
the 11 sequenced MCMV genomes were assessed for evidence
of recombination using Splitstree. Of the 131 genes analysed
(the remaining genes were identiﬁed as having too few informa-
tive sites), 62 (47.1%) were identiﬁed as having statistically
signiﬁcant evidence for recombination (PHIo0.05). These genes
were further analysed using GARD to identify the positions of the
identiﬁed recombination breakpoints within the gene sequence.
Codon-aligned sequences were analysed using GARD, and statis-
tically signiﬁcant topological incongruencies identiﬁed by KH
testing (po0.01). Using this methodology, four genes (m18,
m19, M93 and m170) resulted in PHIo0.05 but no signiﬁcant
topological incongruencies, and three genes (m120, m136, and
m146) were not tested by GARD as fewer than seven unique geneWP15B C4B
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Fig. 1. Evidence for recombination within the MCMV genome. (A) Aligned genome
sequences were analysed for evidence of recombination using SplitsTree4.
Reticulate pattern representations of aligned genomes indicate conﬂicting phylo-
genetic signals within the alignment. The PHI test indicates that these signals are
due to recombination (F¼0.00).
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Fig. 2. The effects of recombination on the genome of MCMV, as identiﬁed by RDP (l
unsuitable for GARD analysis (genes in grey). Recombination occurs throughout the gesequences were available. In HCMV, the gB gene has seven
experimentally identiﬁed recombination breakpoints (Haberland
et al., 1999), three of which can be identiﬁed by GARD within
aligned gB sequences from the Genbank database (data not
shown). Our analysis identiﬁes six breakpoints within the MCMV
gB gene (M55).
Overall, 108 recombination breakpoints were identiﬁed in 55
genes (Fig. 2), with up to six breakpoints identiﬁed within indivi-
dual genes. Obviously this analysis results in an underestimation of
the number of recombination breakpoints within the MCMV
genome, as not only were 39 genes excluded from the analysis
but the approximately 35 kb (15%) of the genome with no as yet
identiﬁed coding potential was also not analysed. Therefore, statis-
tical tests of recombination were performed across the aligned
genome, with high numbers of recombination events identiﬁed
across the entire genome (ranging from 126 identiﬁed by 3seq,
to 226 identiﬁed by RDP and Bootscan), with 86 recombination sites
identiﬁed by more than ﬁve analyses (Fig. 2 and Supplementary
data, Table S1)—although the distribution of these breakpoints is
not random, this equates to 0.373 breakpoints per kb. If examining
the terminal regions of the MCMV genome these values are much
higher—for example, within the m02 gene family there are
2.3 breakpoints per kb. Similar recombination site frequencies were
detected in the genomes of ss-DNA viruses (Lefeuvre et al., 2009).
The four viruses isolated from the same individual (C4A, B, C and D)
contain a high number of putative recombination breakpoints.
Analysis of these four strains alone identiﬁes 14 recombination
events (26 putative recombination breakpoints). For eight of these
recombination events the parental sequences are derived from two
of the co-infecting viruses, demonstrating the dynamic nature of
recombination between co-infecting MCMV strains. Whilst the
contribution of recombination to the evolution of the MCMV
genome is evident, the ratio of recombination rate to mutation rate
(R/yW) is 0.041 for MCMV, indicating most variability is still the
result of point mutation.
A recent study of HSV-1 genomes has demonstrated that these
viruses also have mosaic genomes which appear to be undergoing
frequent recombination, at a much higher rate and more recently
than was found for VZV (Norberg et al., 2011). However, due to
differing methodologies a comparison of recombination frequen-
cies between MCMV and HSV-1 is not possible.
We have previously identiﬁed several genes within the MCMV
genome which exist as multiple, distinct genotypes, and it has
been postulated that these genotypes serve to allow the virus to
interact with polymorphic components of the host immune responseines above) and GARD (lines below) analysis. Twenty-one gene alignments were
nome, although predominantly at the genomic termini.
Fig. 3. Recombination resulting in genotype switching within MCMV genes. The recently sequenced Smith strain variant MCMV-wt1 appears to be a recombinant between
Smith and K181. Recombination appears to have occurred within the m03 gene, and within the m06 gene (dotted boxes). Recombination within m06 has occurred
between the 2nd and 3rd conserved indels (boxes) which delineate m06 genotypes, generating a new, non-parental m06 genotype.
L.M. Smith et al. / Virology 435 (2013) 258–268 261(Corbett et al., 2010; Smith et al., 2006; Voigt et al., 2003).
By examining all of the available sequences (including gene
sequences within the EMBL databases) we have assigned geno-
types to 22 genes within the MCMV population (whilst admitting
that the determination of a genotype without evidence of
phenotype variability is in some ways a matter of personal
preference, Supplementary data, Table S2). Of the 108 breakpoints
identiﬁed by GARD, 45 are found within these genes—suggesting
that recombination may occur preferentially in these genes
(t-test, po0.001) allowing MCMV to rapidly alter speciﬁc genes
in the face of a new host challenge. The potential for recombina-
tion to alter viral genotype may be seen in MCMV strain MCMV-
WT1 (Cheng et al., 2010). This was reported to be an isolate of the
Smith strain of MCMV, with sequence variation in several genes.
Upon examination however, we believe that this virus strain may
actually be a recombinant between the Smith and K181 labora-
tory strains, with two distinct recombination events (from m03 to
m06, and from M49 to approximately M90) in addition to a 94 nt
duplication between M59 and m69. One of the putative recombi-
nation sites is within the m06 gene, between two of the indels
which we have previously used to delineate m06 genotypes
(Smith et al., 2006). This results in recombination between
genotype 2 (Smith) and genotype 3 (K181) to form genotype 4
(the genotype found in viral strain G4; Fig. 3). Work is currently
underway in our laboratory to quantitate the differential effects
of different m06 genotypes on downregulation of MHC class I
molecules in infected cells.Selective pressures on coding sequences
Given the persistent nature of MCMV infection, the virus
is exposed to the host immune system for long periods of time,
both during initial infection and during periodic reactivationsfrom latency. Whilst MCMV encodes multiple functions which
allow the virus to evade host immune responses, the capacity
for immune mediated selection acting on viral genes is evident.
We codon-aligned 116 of the 166 open reading frames for our
analysis. The remaining genes were not analysed as there were
either too few unique sequence variants or too few informative
sites within the alignment. Over 90% of the coding sequences
analysed had ratios of nonsynonymous to synonymous amino
acid substitutions (dN/dS ratios) of less than 0.6, suggesting almost
all MCMV genes are under purifying selection. Indeed
46 genes have dN/dS ratios of less than 0.2, with 15 of these having
dN/dS ratios of less than 0.1, demonstrating the strength of the
purifying selection acting of individual genes (Fig. 4A). Five genes
(M46, M85, M92, M96 and m135) actually have 100% amino acid
identity across all 11 viral strains, and for a further six genes a single
viral strain contained a single amino acid change (mainly in the
Smith sequence, possibly suggesting sequence errors in this genome).
Renzette et al. (2011) suggested that up to 5% of HCMV ORFS were
under positive selection, with dN/dS values being particularly
elevated in envelope genes. In contrast we identiﬁed only one MCMV
gene, m120.1, as under positive selection as determined by dN/dS
across the codon alignment (dN/dS¼1.67). This recently identiﬁed
gene (Brocchieri et al., 2005) has been shown to co-localise within
the mitochondria of infected cells, and is non-essential for viral
growth in vitro (Tang et al., 2006). However its exact function is yet
to be determined, and thus the exact nature of the selection
pressures acting on this gene is unclear.
As would be expected, the conserved core genes of herpes-
viruses (those found in all herpesviruses) are under much higher
levels of purifying selection than the more recently acquired
CMV-conserved, rodent CMV (mouse and rat CMV) conserved,
or MCMV-speciﬁc genes (Fig. 4B).
Whilst only m120.1 was under positive selection, it is possible
that individual codons may be under differential selection
dN/dS range
N
um
be
r o
f g
en
es
<
0.
1
0.
1-
0.
2
0.
2-
0.
3
0.
3-
0.
4
0.
4-
0.
5
0.
5-
0.
6
0.
6-
0.
7
0.
7-
0.
8
0.
8-
0.
9
0.
9-
1.
0
>
1.
00
5
10
15
20
25
30
35
* *
*
0.01
0.1
1
10
Co
re
 h
er
pe
sv
iru
s g
en
es
G
en
es
 in
 a
ll 
CM
V
s
R
od
en
t C
M
V
 sp
ec
ifi
c 
ge
ne
s
M
CM
V
 sp
ec
ifi
c 
ge
ne
s
dN
/d
S
Fig. 4. Evidence of selection within MCMV genes as identiﬁed by ratios of
nonsynonymous to synonymous amino acid substitutions (dN/dS). (A) Almost
all MCMV genes are under strong (dN/dSo0.6) purifying selection, with only
m120.1 having a dN/dS greater than 1. (B) MCMV-speciﬁc genes (as opposed to
genes found in rodent cytomegaloviruses, all cytomegaloviruses, or all herpes-
viruses) have higher (although still less than one) dN/dS ratios.
Table 1
Virus strained described in this work.
Strain Location of isolation Genome size (bp) Accession number
Smith St Louis, USA 230, 278 NC_004065
K181 Wisconsin, USA 230, 301 AM886412
C4A Canberra, Australia 230, 111 EU579861
C4B Canberra, Australia 230, 154 HE610452
C4C Canberra, Australia 229, 924 HE610453
C4D Canberra, Australia 229, 935 HE610456
G4 Geraldton, Australia 230, 227 EU579859
WP15B Walpeup, Australia 230, 118 EU579860
N1 Nannup, Australia 229, 884 HE610454
AA18D Macquarie Is. Australia 229, 543 HE610451
N07 Beacon Is. Australia 229, 452 HE610455
WT1 nUSA 230, 408 GU305914
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domains. We assessed the selection pressures on individual
codons in each of the 116 gene alignments using three different
approaches each of which have differing sensitivities and limita-
tions, namely SLAC, FEL, and REL (Supplementary data, Table S3).
For an in depth discussion of the approaches see Kosakovsky Pond
and Frost (2005). Those codons identiﬁed by two or more of the
tests are considered to have the strongest evidence for selection
(po0.1 for SLAC, po0.05 for FEL, Bayes Factor 4100 for REL). Of
the 54,449 codons in the genes being assessed only 17 (0.03%)
have strong evidence for positive selection, with 11 of these being
in genes of the m02 gene family; however, overall 534 codons
(0.9%) within 59 genes are identiﬁed as being under positive
selection by at least one test (Table 1). The gene which was
identiﬁed as being under ‘global’ positive selection, m120.1, has
11 of its 91 codons under positive selection (although it should be
noted that these were only identiﬁed using REL, the test most
susceptible to false positives; (Kosakovsky Pond and Frost, 2005)).
We and others have previously shown that genes such as m04
and m157 exist as multiple distinct genotypes within the viral
population (Corbett et al., 2007; Smith et al., 2006; Voigt et al.,
2003). A variation of the FEL test used for codon-based selection,
IFEL, can be used to identify codons under selection on interiorbranches of the phylogeny (i.e. in ancestral sequences), rather
than on the terminal branches or tips (the sampled viral
sequences). Comparison of all available m04 sequences demon-
strates that more codons were identiﬁed as being under positive
selection on the interior branches than at the tips (Fig. 5).
Presumably those codons under ‘interior only’ positive selection
are those responsible for formation of viral genotypes, which are
subsequently retained within the viral population. Five of the
six codons identiﬁed as being under positive selection by FEL
(i.e. selection at the ‘tips’ of the tree) are also identiﬁed as being
under positive selection by IFEL. These positively selected non-
synonymous substitutions on both internal and terminal branches
(persistent substitutions) must of necessity be adaptive at both
individual host and population levels. Only one codon (123) is
identiﬁed by FEL as being positively selected but not IFEL—this
selection is therefore recent, and may therefore only be adaptive
within speciﬁc hosts rather than the population as a whole.
Conversely, 709 codons (1.30%) within 110 genes have strong
evidence of purifying selection (by two or more tests), with
overall 6910 (12.6%) codons showing evidence of purifying selec-
tion by at least one test (Table 2), with negatively-selected codons
being identiﬁed in all but two of the genes analysed (M147 gives
us discordant results, with no codons being identiﬁed as under
negative selection, yet the overall dN/dS is 0.26). The degree of
purifying selection within MCMV genes is in some ways quite
surprising, particularly considering that a number of the genes
appear to be dispensable for viral replication (Bubic et al., 2004;
Krmpotic et al., 2002; Manning and Mocarski, 1988) as deletion of
these genes results in limited or no reduction of viral replication
in laboratory mice. Given the non-essential nature of these genes,
why should their sequence be under such strong purifying
selection? It is possible that whilst individual genes are not
essential within a single, speciﬁc host animal, they may be
required for growth in other members of the host population
(which, it should be remembered, will be highly outbred with a
wide variety of immune response genes). Thus an individual virus
retains genes which it does not require, and the periodic utility of
these genes still results in purifying selection to retain gene
function.
Variability of immune system targets—CTL escape
CD8þ T-cells control viral infections by killing virally infected
cells in an MHC-restricted manner. The importance of CTL control
of viral infections can be seen by the selection of CTL-escape
mutants in viral infections such as HIV and hepatitis B and C
(Borrow et al., 1997; Goulder et al., 2001; Weiner et al., 1995) and
reviewed by (Wieland and Chisari, 2005). These escape mutants
generally have mutated CTL-epitope peptides, which are unable
to be presented by MHC class I, or have altered (generally
Fig. 5. Codons within the m04 gene identiﬁed as being under positive selection on interior branches of the phylogenetic tree are evidence of selection in ancestral
sequences. Selection on both interior branches! and tips # suggests mutations which are adaptive at both population and individual levels, whilst selection only at the tips
suggests ongoing mutation. Putative m04 genotypes (1–7) are identiﬁed based on the nucleic acid NJ tree.
Table 2
Codons within 116 MCMV genes which are identiﬁed as being under positive or purifying selection by one or more tests. Results are shown for codons identiﬁed by only
one test, by two different tests, or by all tests. For example, SþF means codons identiﬁed by both SLAC and FEL. No codons were identiﬁed as being under positive selection
by SLAC alone.
Positive selection Negative selection
Test FEL REL SþF FþR SLAC FEL REL SþF SþR FþR SþFþR
Total codons 17 500 0 17 8 192 5999 56 2 517 134
L.M. Smith et al. / Virology 435 (2013) 258–268 263lowered) binding efﬁciencies for MHC class I such that the
dynamics of antigen presentation and CTL killing are altered.
CTL-escape can also be seen in herpesviruses such as human
herpesvirus 4, where two HLA-A11-restricted epitopes derived
from EBNA4 were identiﬁed. In populations with high HLA-A11
frequencies (450%), HHV4 sequences were shown to have
mutated these epitopes at the anchor residues resulting in
impaired peptide presentation (de Campos-Lima et al., 1993; de
Campos-Lima et al., 1994). All herpesviruses encode multiple
genes which function to downregulate MHC class I expression
on the cell surface, and thus to evade cytotoxic T-cell killing of
infected cells (Abendroth et al., 2001; Glosson and Hudson, 2007;
Hassink et al., 2005; Ishido et al., 2000; Noriega and Tortorella,
2009). Therefore control of CMV infection by CD8þ T-cells must
form an important part in host-defences against infection, parti-
cularly in the control of viral reactivation from latency. Mutating
the anchor residue of the immunodominant ie1 CTL epitope
within the Smith strain of virus was shown to have potentially
signiﬁcant effects on viral infection, with polyclonal ie1-speciﬁc
CTLs being unable to recognise cells infected with this mutant
virus. This mutant virus was also unable to prime an ie1 epitope-
speciﬁc CTL response in vivo (Simon et al., 2006). By utilising a
library of overlapping peptides derived from the known coding
potential of MCMV, Munks et al. (2006) identiﬁed the complete
repertoire of H2b restricted CD8þ T-cell epitopes within theSmith strain of virus. Of the 23 identiﬁed epitopes (10 Db
restricted and 13 Kb restricted), 20 are conserved in all strains
of MCMV that have been sequenced (Table 3). One epitope (the
M97 peptide IISPFPGL) is conserved between all viral strains but
the protein sequence immediately N-terminal to the epitope is
variable, suggesting possible differences in proteasomal cleavage
and that this epitope may not be processed in all viral strains. Of
the three epitopes in which variation can be seen, two of them
(the M38 peptide SSPPMFRV, and the M112 peptide AAVQSATSM)
are only different in one viral strain. Only one of the CD8 epitopes,
the m04 peptide MSLVCRLVL, shows extensive variation between
viral strains. Indeed, the epitope presented during infection with
the Smith strain of MCMV is only found in one other strain of
virus, G4. This m04 nonamer sequence exists as ﬁve distinct
variants in the other sequenced strains of virus, but interestingly
none of the codons within this region are found to be under
positive selection (see below). Several H2d restricted CD8 epi-
topes have been identiﬁed by other researchers (Gold et al., 2002;
Holtappels et al., 2000, 2002a, 2002b, 2002c; Lyons et al., 1996;
Reddehase et al., 1986, 1989) and a similar pattern can be
seen—ﬁve of these epitopes identiﬁed in the Smith virus are
conserved in all other sequenced strains of MCMV, with the pp89
peptide YPHFMPTNL and the m04 peptide YGPSLYRRF existing as
distinct variants in other viral strains. Overall, of the 16 nonamer
CD8 epitopes described, four of them (25%) are variable in at least
Table 3
Conservation of CD8þ T cell epitopes within MCMV strains.
Gene MHC class I Sequence Variation
m04 Db MSLVCRLVL MSPVYRLVL (C4A, C4C, NO7)
MFPVRRLML (C4D, WP15B)
MSLTHRPLLV (K181)
MSLGCRLML (C4B)
MSLASHLPL (AA18d, N1)
M33 Db GGPMNFVVL
M36 Db GTVINLTSV
M38 Kb SSPPMFRV SSPPMLRV (C4D)
Kb STYTFVRT
M44 Db ACVHNQDII
M45 Db HGIRNASFI
M57 Kb SCLEFWQRV
M77 Db GCVKNFEFM
M78 Kb VDYSYPEV
M86 Db SQNINTVEM
M97 Kb IISPFPGL (Variation immediately N-term to epitope)
M100 Kb RIIDFDNM
M102 Db SVAHIYVGVGGVCRI
Kb GVCRISIVDLRFAVL
Kb RLAHSSPRIFRRVRS
M112 AAVQSATSM AAVQSANSM (C4C)
ie3 Kb RALEYKNL
ie3 Kb VRKAVDETRARMGMR
m141 Kb VIDAFSRL
m164 Kb GTTDFLWM
Db WAVNNQAIV
m04 Dd YGPSLYRRF FGPSLYRRL (C4A, C4D, NO7)
FGPSLYRRF (WP15B, C4B)
FGPSLCRRF (AA18d, N1)
m18 Dd SGPSRGII
M45 Dd VGPALGRGL
M83 Ld YPSKEPFNF
M84 Kd AYAGLFTPL
ie1 Ld YPHFMPTNL YPHFMPPSL (C4A, C4B, C4C, C4D, AA18d, WP15B, G4)
YPHFIPPSL (NO7)
YLDFMPPNL (N1)
m164 Dd AGPPRYSRI
L.M. Smith et al. / Virology 435 (2013) 258–268264one virus strain. This compares to the variability seen in all
overlapping nonamers in the genes which contain these epitopes
(1345 out of a possible 8594 nonamers (15.6%) exhibit variabil-
ity). The identiﬁed CD8 epitopes are thus more variable than their
context however there is no evidence that any of the codons
utilised by these peptides are under positive selection.
The organ of persistence and transmission of MCMV is the
salivary gland. Viral replication (and therefore viral shedding and
transmission) in this organ is predominantly controlled by CD4þ
T-cells (Jonjic et al., 1989). Of the 20 CD4þ T-cell epitopes thus
far identiﬁed (Arens et al., 2008; Walton et al., 2008), ﬁve of them
are variable between viral strains (the M45 peptide AVSAANAAV-
NAAAAA is only different in strain NO7, but the m09 peptide, both
m14 peptides, the m146 peptide and the M45 peptide TPAATT-
PAATAVENR all exist as multiple distinct variants in the other
viral strains; Table 4). However, comparing the variability seen in
the 15mer CD4 epitopes (ﬁve out of 20%, or 25%, are variable)
with the innate 15mer variation within these epitope-containing
genes (2063 out of 6995 15-mers, or 29.5%, are variable) suggests
no pressure to evade CD4 control. Interestingly, one epitope does
show signs of positive selection—codon 140 of the m09 gene is
identiﬁed as being under positive selection using FEL, but even
should we accept this evidence, the codon is within the central
region of the putative epitope, and thus the functional conse-
quences of any amino acid change remain to be determined.
Moreover without an understanding of the MHC class I and IIhaplotypes present in the mouse populations sampled, these data
cannot be used to determine if MCMV uses sequence variation as
a means of T cell escape. These data simply indicate the level of
variability in the known epitopes relative to other peptide
components of the proteins in question.
Variability of immune system targets—antibody escape
Antibody-escape mutants are able to persist and transmit in
the face of otherwise neutralising antibodies. The envelope of
MCMV, as in all herpesviruses, contains a number of glycoprotein
complexes which are involved in cell entry and cell-to-cell spread
and given their position on the virion it is not surprising that they
are the main targets for serum antibodies after infection. The
importance of antibody in control of MCMV infection is some-
what unclear. It has been reported that neutralising antibodies
are produced 3–5 days post-viral infection (Araullo-Cruz, 1979),
and transfer of either antibodies or memory B-cells to naı¨ve mice
is protective against subsequent MCMV challenge (Jonjic et al.,
1994; Klenovsek et al., 2007). However, this transfer of memory
B-cells is much more effective in control of virus in the peripheral
organs rather than in the organ of transmission, the salivary gland
(a 3–4 log reduction in viral titres in the spleen, as opposed to a
1 log reduction in the salivary gland (Klenovsek et al., 2007)) and
infection kinetics in wild-type and B-cell deﬁcient mice are
identical (Jonjic et al., 1994). The fact that multiple and
Table 4
MHC class II epitopes for Smith strain MCMV in C57BL/6 mice.
Gene Epitope Variation
m09 GYLYIYPSAGNSFDL GYLYIYPDAGNNFYL (C4A, C4B, N1)
GYLYIYPAAGSNFYI (AA18d)
GYLYIYPDAGTNFYI (NO7)
GYLYIYPSAGNNFYL (K181, G4)
GYLYIYPIAGSNFYI (C4C, C4D)
m14 VTDNIYISSQVSSNQ VTDNVYISSQVSSNQ (C4A, K181, N1)
DTANVYISSKVSSNQ (C4B, C4C, C4D, WP15B, AA18d)
VTDNVYISSKVSSNQ (G4)
m14 YISSQVSSNQLGLIC YISSKVSSNQLGLIC(C4B, C4C, C4D, NO7, WP15B, AA18d, G4)
M18 NERAKSPAAMTAEDE
M25 LYETPISATAMVIDI
M25 SLGNFVYNFSRALEE
M25 VYNFSRALEELRGMI
M25 NHLYETPISATAMVI
M45 AVSAANAAVNAAAAA AVSAANAAVNAGAAA (NO7)
M45 TPAATTPAATAVENR TPAATTPAAVENR (C4A)
TPAATTPAAAAVENR (C4B, C4C, N1, G4, WP15B)
TPAATTPATAAVENR (C4D)
TPAATTPAAAVENR (AA18d)
TPAATTSAAAAVENR (K181)
TPAATTPAAAAVEKR (NO7)
M45 QATPSTPIPIPAPRC
M45 RPAVCGPGVSVVSGG
M83 TLRYAKANGTPPDSL
M104 LKRFIYAEPTILEEE
M112 DLRQWTYESARVLDC
M112 TYESARVLDCTNGEG
ie3 DRTAGGYVAPNAHKK
m139 GSPWKTSAVTVSRKA
m139 TRPYRYPRVCDASLS
m141 LVVFSDPNADAATSV
m142 RYLTAAAVTAVLQDF
m142 RSRYLTAAAVTAVLQ
m146 MTTPSPIRVRAIAVW MTTPSLIRVRGIAVW (C4B, NO7, WP15B)
MTTPSPIRVRGIAVW (C4A, G4)
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shown (Gorman et al., 2006) and that wild mice have been shown
to be infected naturally with multiple strains of MCMV (Booth
et al., 1993; Gorman et al., 2006) suggests that neutralising
antibodies play little part in controlling MCMV infection in mice.
To this end, the variability of the surface glycoproteins between
MCMV strains is of interest. The MCMV gB gene encodes the major
glycoprotein complex of the molecules gp52, gp105, gp128 and
gp150, and is the target of most of the circulating anti-MCMV
antibodies in infected mice. Despite this, the overall dN/dS ratio of
the gene is 0.175 indicating strong purifying selection, with over
16% (155 out of 937) of the codons identiﬁed as being under
purifying selection: obviously, for gB, the functional requirements
of conserving protein function outweigh any advantages to be
gained from escaping antibody control. Interestingly, two regions
of the gene do appear to be subject to positive selection pressures.
Three codons between amino acids 42 and 71 are identiﬁed as
being under positive selection, in the region previously identiﬁed as
a putative non-neutralising epitope (Xu et al., 1996). Four of the
seven codons between amino acids 487 and 494 are also identiﬁed
as being under positive selection pressure. This region is immedi-
ately N-terminal to the gp52/gp105 cleavage site, and has also been
shown to contain a minor antibody-binding region (Xu et al., 1996).Conclusion
Overall, the genome of MCMV contains similar levels of nucleo-
tide variation to those seen in clinical strains of HCMV; howeverthere is no evidence of either the intramolecular recombination or
the passage-related mutation seen in HCMV. Inter-molecular
recombination appears to be a major driver of MCMV genome
evolution, and may be a method by which MCMV switches
genotypes rapidly. There are only low levels of positive selection
even on viral surface glycoproteins or immune targets, with no
evidence of immune escape mutation. The ‘lifestyle’ of MCMV, with
persistent infection, immune evasion and multiple infection, is
therefore mirrored in the evolution of the viral genome.Funding
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Medical Research Council (Australia), Grant IDs 572574 and
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Viruses
The viruses used in these analyses are listed in Table 1. Viral
strains Smith, K181Perth, N1, G4, C4A, C4B, C4C, C4D, and WP15B
have been described previously (Booth et al., 1993; Gorman et al.,
2006; Osborn, 1982; Smith et al., 2006; Smith, 1954). AA18d
was isolated from the salivary glands of a mouse trapped on
Macquarie Island, and NO7 was isolated from the salivary
glands of a mouse trapped on Beacon Island, Western Australia.
L.M. Smith et al. / Virology 435 (2013) 258–268266All ‘‘wild-derived’’ viruses were isolated by plaque puriﬁcation on
BALB/c-derived murine embryonic ﬁbroblasts (MEF), and were
subsequently minimally passaged (o10 passages) in vitro prior
to sequencing. Strain WT1 was reported by Cheng et al. (2010) to
be a variant of Smith, and was kindly supplied by Dr W.
Yokoyama (Washington University, School of Medicine).Sequencing
The complete genome sequences of the Smith, K181Perth, G4,
C4A and WP15B strains have been described previously
(Rawlinson et al., 1996; Smith et al., 2008). Other viruses were
infected onto MEFs at an MOI of 5, and at 48–72 h post-infection
cells were frozen and thawed to release cell associated virus.
Pelleted virions were DNAseI treated prior to lysis to remove any
contaminating murine genomic DNA, and then lysed with protei-
naseK/SDS prior to phenol:chloroform extraction to purify viral
genomic DNA. Samples were RNAse-treated prior to assessing the
genomic DNA by agarose gel electrophoresis. Genomic library
preparation and sequencing was performed on the Roche
FLX Next Generation sequencer, at the Lotterywest State Biome-
dical Facility at Royal Perth Hospital, Perth, Western Australia,
Australia.Sequence analysis
Viral genomic sequences were de novo assembled, and contigs
were assembled against the Smith genome sequence, using the
CLC Genomic Workbench. Coverage for each virus ranged from
25 to 75 . Genomes were annotated by BLAST analysis of viral
open reading frames, with manual adjustment to reference
sequences. Sequences have been deposited in the EMBL sequence
database (accession numbers in Table 1). Complete genomes were
aligned using Multi-LAGAN, implemented at http://genome.lbl.
gov/vista and manually edited for optimal alignment. Recombina-
tion was identiﬁed within the aligned genomes using multiple
analytical approaches; SplitsTree and the PHI test (Huson and
Bryant, 2006). Bootscan, SiScan, RDP, GENECONV, Chimaera,
MaxChi and 3Seq were performed within the RDP software
(Martin et al., 2010), with a Bonferroni correction for multiple
analyses. Since these tests have different sensitivities, and differ-
ent levels of false results (both positive and negative), only
breakpoints detected by multiple tests have been described. Gene
sequences from the 11 available genomes, plus sequences extant
in the EMBL database were codon-aligned using JCoDa (Steinway
et al., 2010). Selection and recombination within gene sequences
were assessed using the HyPhy package, implemented using the
Datamonkey server (www.datamonkey.org). Brieﬂy, nucleotide
substitution models were determined for each codon-aligned
gene alignment, and each gene was then analysed for recombina-
tion signals using Splitstree. Should evidence for recombination
have been identiﬁed, the putative recombination sites were
identiﬁed using GARD (Kosakovsky Pond et al., 2006). Individual
codons of the alignment were then analysed for evidence of
selection using SLAC, FEL and REL (Kosakovsky Pond and Frost,
2005). Either Neighbour-Joining or GARD-inferred phylogenetic
trees (for each recombinant fragment) were used for the selection
analyses. As Datamonkey requires unique gene sequences, any
genes where fewer than seven unique sequences were available
(either due to identical gene sequences, or putative sequence-
based errors) were not analysed. Overall dS/dN ratios for indivi-
dual genes were calculated using SNAP (Korber, 2000) implemen-
ted at www.hiv.lanl.gov.Acknowledgments
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